Published in Gut on January 01, 1992
Helicobacter pylori: the cancer link. J R Soc Med (1996) 2.15
Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut (1997) 1.88
Nature meets nurture: molecular genetics of gastric cancer. Hum Genet (2009) 1.87
Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ (1994) 1.78
The relationship between Helicobacter pylori infection and Alzheimer's disease in Japan. J Neurol (2011) 1.44
Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis. Gut (1996) 1.23
Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci (2007) 1.20
Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer (1998) 1.15
Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux? Gut (2001) 1.14
Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut (1998) 1.14
Research of Helicobacter pylori infection in precancerous gastric lesions. World J Gastroenterol (2000) 1.12
Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol (1999) 1.09
Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev (2015) 1.05
Gastric pathology in patients with common variable immunodeficiency. Gut (1999) 1.04
Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol (2010) 1.02
Subtypes of intestinal metaplasia and Helicobacter pylori. Gut (1992) 1.00
Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer. J Med Microbiol (2013) 0.97
Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol (2012) 0.97
Helicobacter pylori and early gastric cancer. Gut (1994) 0.96
Comparison of precancerous conditions: atrophy and intestinal metaplasia in Helicobacter pylori gastritis among Chinese and Dutch patients. J Clin Pathol (2001) 0.92
Coordinate increase of telomerase activity and c-Myc expression in Helicobacter pylori-associated gastric diseases. World J Gastroenterol (2004) 0.91
DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus. World J Gastroenterol (2014) 0.91
Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. J Clin Pathol (1995) 0.90
Immunohistochemical testing for Helicobacter Pylori existence in neoplasms of the colon. BMC Gastroenterol (2008) 0.89
Dual specimens increase the diagnostic accuracy and reduce the reaction duration of rapid urease test. World J Gastroenterol (2010) 0.84
Carcinogenic Helicobacter pylori in gastric pre-cancer and cancer lesions: association with tobacco-chewing. World J Gastroenterol (2014) 0.84
Helicobacter pylori infection and gastric carcinogenesis in rodent models. Semin Immunopathol (2012) 0.84
Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobactor pylori seropositivity, gastric atrophy and gastric cancer in Japanese. BMC Gastroenterol (2009) 0.84
Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. World J Gastroenterol (2013) 0.83
Pathophysiological effects of long-term acid suppression in man. Dig Dis Sci (1995) 0.82
Paradoxical role of SOX2 in gastric cancer. Am J Cancer Res (2016) 0.81
A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers. Korean J Intern Med (2015) 0.81
No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese. Gastric Cancer (2010) 0.80
Eradication of Helicobacter pylori: therapies and clinical implications. Postgrad Med J (1992) 0.80
Presentation and prognosis of gastric cancer in patients aged 80 years and older. World J Surg (2004) 0.79
Prohormone convertase furin has a role in gastric cancer cell proliferation with parathyroid hormone-related peptide in a reciprocal manner. Dig Dis Sci (2002) 0.78
Early-onset gastric cancer: Learning lessons from the young. World J Gastrointest Oncol (2010) 0.78
Relationship between persistence of Helicobacter pylori and dysplasia, intestinal metaplasia, atrophy, inflammation, and cell proliferation following partial gastrectomy. Dig Dis Sci (1999) 0.78
Seroprevalences ofHelicobacter pylori infection and chronic atrophic gastritis in the united Republic of Tanzania and the Dominican Republic. Environ Health Prev Med (2004) 0.78
Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation. Biomed Res Int (2016) 0.78
Long-term effects of Helicobacter pylori eradication on intestinal metaplasia in patients with duodenal and benign gastric ulcers. Dig Dis Sci (2000) 0.77
Gastric Intestinal Metaplasia in an Underserved Population in the USA: Prevalence, Epidemiologic and Clinical Features. Gastroenterol Res Pract (2013) 0.77
Pathophysiology and clinical relevance of Helicobacter pylori. Yale J Biol Med (1994) 0.76
Immunohistochemical evaluation of keratin 20 expression in intestinal metaplasia types I to III. J Clin Pathol (1996) 0.75
Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux. World J Gastroenterol (2014) 0.75
A review of the clinicopathologic characteristics of intestinal metaplasia in gastric mucosal biopsies. Pan Afr Med J (2016) 0.75
Kupffer cells induce Notch-mediated hepatocyte conversion in a common mouse model of intrahepatic cholangiocarcinoma. Sci Rep (2016) 0.75
Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome. World J Gastroenterol (2005) 0.75
Analyzing the influence of gastric intestinal metaplasia on gastric ulcer healing in Helicobacter pylori-infected patients without atrophic gastritis. BMC Gastroenterol (2017) 0.75
No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese. Gastric Cancer (2010) 0.75
Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet (1983) 23.90
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand (1965) 22.65
Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust (1985) 10.75
Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet (1990) 9.49
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology (1988) 8.27
Campylobacter pylori and peptic ulcer disease. Gastroenterology (1989) 7.42
Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology (1987) 7.27
Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol (1987) 7.09
Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet (1989) 6.58
The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol (1972) 6.07
Campylobacter pylori antibodies in humans. Ann Intern Med (1988) 6.02
Antibody to the gastric campylobacter-like organism ("Campylobacter pyloridis")--clinical correlations and distribution in the normal population. J Med Microbiol (1986) 4.95
Spiral bacteria of the gastric antrum. Lancet (1984) 4.74
Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut (1985) 3.48
Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer (1955) 3.12
Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy. J Clin Pathol (1986) 2.38
Chronic gastritis--a pathogenetic approach. J Pathol (1988) 2.31
Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst (1976) 2.14
Prevalence of gastritis in a rural population. Bioptic study of subjects selected at random. Scand J Gastroenterol (1968) 2.09
Gastric glycerolipid as a receptor for Campylobacter pylori. Lancet (1989) 1.72
Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol (1988) 1.56
Intestinal metaplasia of the gastric mucosa: a gross and microscopic study of its distribution in various disease states. J Natl Cancer Inst (1968) 1.40
The epidemiology and pathogenesis of chronic gastritis: three etiologic entites. Front Gastrointest Res (1980) 1.16
Time trend in the prevalence of intestinal metaplasia in Japan. Cancer (1983) 1.12
Diet and chronic atrophic gastritis: a case-control study. J Natl Cancer Inst (1986) 1.05
Helicobacter gastritis and intestinal metaplasia in a gastric cancer family. Lancet (1990) 1.05
Classification principles and genetics of chronic gastritis. Scand J Gastroenterol Suppl (1987) 1.04
Chronic atrophic gastritis and gastric mucosal atrophy--one and the same. Gastrointest Endosc (1983) 0.92
Intestinal metaplasia in Japan: association with diet. J Natl Cancer Inst (1982) 0.90
Geographical pathology of duck livers infected with duck hepatitis B virus from Chiba and Shimane in Japan and Shanghai in China. Cancer Res (1988) 0.89
Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet (1990) 9.49
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology (1988) 8.27
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J Clin Microbiol (1986) 5.15
The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology (1996) 4.69
Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet (1993) 4.55
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39
Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology (1989) 4.23
Functional gastroduodenal disorders. Gut (1999) 3.74
Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol (1994) 3.22
Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet (1997) 3.12
Needle-knife sphincterotomy as a precut procedure: a retrospective evaluation of efficacy and complications. Endoscopy (1996) 3.12
[Diversity of complaints in manifesting carcinoma of the gallbladder]. Ned Tijdschr Geneeskd (2007) 3.10
Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology (2001) 2.85
Recurrent massive haematemesis from Dieulafoy vascular malformations--a review of 101 cases. Gut (1986) 2.74
Regular review: treatment of Helicobacter pylori infection. BMJ (2000) 2.73
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis (1996) 2.66
Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age. Gastrointest Endosc (1996) 2.54
Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut (1998) 2.38
The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology (1999) 2.37
Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter (1996) 2.26
Collagenous sprue--an unrecognized type of malabsorption. N Engl J Med (1970) 2.21
Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol (1997) 2.18
Heterogeneous Helicobacter pylori isolates from members of a family with a history of peptic ulcer disease. Gastroenterology (1996) 2.17
A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther (1999) 2.14
Treatment of bile duct lesions after laparoscopic cholecystectomy. Gut (1996) 2.12
Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from China. J Infect Dis (1998) 2.09
Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology (1978) 2.07
[Changed diagnosis and treatment of hepatocellular carcinoma]. Ned Tijdschr Geneeskd (1996) 2.04
HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut (1999) 1.94
14C-urea breath test in C pylori gastritis. Gut (1989) 1.89
Time trends in gastric carcinoma: changing patterns of type and location. Am J Gastroenterol (1992) 1.88
cagA-positive Helicobacter pylori populations in China and The Netherlands are distinct. Infect Immun (1998) 1.84
Gastric non-Hodgkin lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA. Am J Clin Pathol (1996) 1.84
Endoscopic palliative treatment in pancreatic cancer. Gastrointest Endosc (1986) 1.84
Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations. Gut (1976) 1.83
Biliary endoprostheses in elderly patients with endoscopically irretrievable common bile duct stones: report on 117 patients. Gastrointest Endosc (1995) 1.82
Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am J Gastroenterol (1996) 1.80
A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology (1997) 1.79
Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther (1999) 1.76
Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology (1988) 1.75
Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group. Eur J Gastroenterol Hepatol (1995) 1.74
Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology (1999) 1.74
Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new (1987) TNM system. Gastroenterology (1989) 1.70
Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension. Eur J Gastroenterol Hepatol (1996) 1.70
Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol (1997) 1.69
Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon. Gastroenterology (1990) 1.67
Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology (1997) 1.67
Impaired anamnestic cellular immune response in patients with Crohn's disease. Gut (1975) 1.65
A patient with osteomalacia as single presenting symptom of gluten-sensitive enteropathy. J Intern Med (1992) 1.64
Surveillance in Barrett's oesophagus: a critical reappraisal. Scand J Gastroenterol Suppl (2002) 1.63
Model bile and bile salts accelerate mucin secretion by cultured dog gallbladder epithelial cells. Gastroenterology (1995) 1.61
Intestinal endotoxemia. Clinical significance. Gastroenterology (1988) 1.59
Benign biliary strictures. Surgery or endoscopy? Ann Surg (1993) 1.59
Loss of E-cadherin expression in early gastric cancer. Histopathology (1999) 1.59
Intragastric balloons for morbid obesity: results, patient tolerance and balloon life span. Br J Surg (1990) 1.58
Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol (1999) 1.57
The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region. J Pathol (1998) 1.56
Follow-up study of individuals with untreated Campylobacter pylori-associated gastritis and of noninfected persons with non-ulcer dyspepsia. J Infect Dis (1988) 1.52
Bile duct injury after laparoscopic cholecystectomy: the value of endoscopic retrograde cholangiopancreatography. Gut (1993) 1.52
Clogging of biliary endoprostheses: a new perspective. Gut (1990) 1.52
Early diagnosis and prevention of sporadic colorectal cancer. Endoscopy (2001) 1.51
Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function. Gastroenterology (2001) 1.51
Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy (1999) 1.51
Palliative treatment of obstructive jaundice by transpapillary introduction of large bore bile duct endoprosthesis. Gut (1982) 1.51
Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer (1999) 1.50
Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication. Gut (1998) 1.50
A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule. Am J Gastroenterol (2000) 1.50
A randomized trial of endoscopic balloon dilation and endoscopic sphincterotomy for removal of bile duct stones in patients with a prior Billroth II gastrectomy. Gastrointest Endosc (2001) 1.49
Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut (1999) 1.49
Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial. Ann Intern Med (1996) 1.48
Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc (2001) 1.48
Diagnostic accuracy of fiberendoscopy in the detection of upper intestinal malignancy. A follow-up analysis. Gastroenterology (1977) 1.44
Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa. J Clin Pathol (1994) 1.44
Analysis of a positional candidate gene for inflammatory bowel disease: NRAMP2. Inflamm Bowel Dis (2000) 1.44
A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction. Endoscopy (1998) 1.44
The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? Scand J Gastroenterol (1995) 1.43
Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis (1994) 1.42
Results of conservative treatment of benign esophageal strictures: a follow-up study in 100 patients. Gastroenterology (1982) 1.42
Stage is a better prognostic indicator than morphologic subtype in primary noncutaneous T-cell lymphoma. Am J Clin Pathol (1990) 1.41
Treatment of instrumental oesophageal perforation. Gut (1984) 1.40
Suppression of Helicobacter pylori infection during intensive care stay: related to stress ulcer bleeding incidence? J Crit Care (2001) 1.40
Gastric metaplasia and Helicobacter pylori infection. Gut (1993) 1.40
Geographical variance in the risk of gastric stump cancer: no increased risk in Japan? Jpn J Cancer Res (1991) 1.39
[Barrett's esophagus: endoscopic treatment of high-grade dysplasia and early cancer]. Ned Tijdschr Geneeskd (2003) 1.39